$0.09
Market Capitalization | 8.7M |
Book Value | - $10.12 |
Earnings Per Share (EPS) | -14.67 |
Profit Margin | -256.77% |
Operating Margin TTM | -528.56% |
Return On Assets TTM | -576.84% |
Return On Equity TTM | 0.0% |
Revenue TTM | 2.9M |
Revenue Per Share TTM | 8.81 |
Quarterly Revenue Growth YOY | 7.8% |
Gross Profit TTM | 1.8M |
EBITDA | -13.3M |
Diluted Eps TTM | -14.67 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 207.4K | - |
Net Income | -1.4M | - |
Net Profit Margin | -664.82% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 901.2K | ↑ 334.5% |
Net Income | -8.9M | ↑ 544.77% |
Net Profit Margin | -986.55% | ↓ 321.73% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 2.6M | ↑ 190.8% |
Net Income | -5.6M | ↓ 36.84% |
Net Profit Margin | -214.27% | ↑ 772.28% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 2.6M | ↑ 0.45% |
Net Income | -3.2M | ↓ 43.4% |
Net Profit Margin | -120.73% | ↑ 93.54% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Revenue | 225.3K | ↑ 0.0% |
Net Income | -2.4M | ↑ 0.0% |
Net Profit Margin | -1.0K% | ↑ 0.0% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Revenue | 302.0K | ↑ 34.04% |
Net Income | -2.7M | ↑ 15.87% |
Net Profit Margin | -905.02% | ↑ 141.89% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 731.0K | ↑ 142.06% |
Net Income | -1.1M | ↓ 60.37% |
Net Profit Margin | -148.19% | ↑ 756.83% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 700.8K | ↓ 4.12% |
Net Income | -2.8M | ↑ 157.78% |
Net Profit Margin | -398.43% | ↓ 250.24% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 789.7K | ↑ 12.68% |
Net Income | 4.6M | ↓ 262.97% |
Net Profit Margin | 576.27% | ↑ 974.7% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 325.5K | ↓ 58.78% |
Net Income | -475.1K | ↓ 110.44% |
Net Profit Margin | -145.94% | ↓ 722.21% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 795.7K | - |
Total Liabilities | 710.7K | - |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.1M | ↑ 160.36% |
Total Liabilities | 1.9M | ↑ 168.53% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.1M | ↓ 49.31% |
Total Liabilities | 5.0M | ↑ 161.64% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.2M | ↑ 13.42% |
Total Liabilities | 2.6M | ↓ 48.05% |
Q4 FY21 | Q/Q Change | |
---|---|---|
Total Assets | 517.9K | ↑ 0.0% |
Total Liabilities | 477.1K | ↑ 0.0% |
Q1 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 297.8K | ↓ 42.5% |
Total Liabilities | 648.5K | ↑ 35.92% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 542.9K | ↑ 82.31% |
Total Liabilities | 9.3M | ↑ 1328.42% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 297.8K | ↓ 45.15% |
Total Liabilities | 648.5K | ↓ 93.0% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 890.8K | ↑ 199.14% |
Total Liabilities | 6.1M | ↑ 835.48% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 890.8K | ↑ 0.0% |
Total Liabilities | 6.1M | ↑ 0.0% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -1.5M | - |
Investing Cash Flow | -3.2K | - |
Financing Cash Flow | 1.6M | - |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -4.1M | ↑ 177.64% |
Investing Cash Flow | -3.2K | ↑ 0.0% |
Financing Cash Flow | 4.6M | ↑ 189.41% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -894.0 | ↓ 99.98% |
Investing Cash Flow | -28.3K | ↑ 784.48% |
Financing Cash Flow | 19.0 | ↓ 100.0% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | -12.6M | ↑ 1406863.76% |
Investing Cash Flow | -2.0K | ↓ 92.78% |
Financing Cash Flow | 12.7M | ↑ 6.658522105E7% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -8.7M | ↑ 420.11% |
Investing Cash Flow | -703.0 | - |
Financing Cash Flow | 8.8M | ↑ 367.49% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.4M | ↓ 72.84% |
Investing Cash Flow | -703.0 | ↑ 0.0% |
Financing Cash Flow | 2.4M | ↓ 72.3% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -8.7M | ↑ 268.24% |
Investing Cash Flow | -703.0 | ↑ 0.0% |
Financing Cash Flow | 8.8M | ↑ 261.06% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -2.4M | ↓ 72.84% |
Investing Cash Flow | -703.0 | ↑ 0.0% |
Financing Cash Flow | 2.4M | ↓ 72.3% |
Sell
Neutral
Buy
Bruush Oral Care Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|
Renaissance Technologies Corp
HRT FINANCIAL LLC
UBS Group AG
Geode Capital Management, LLC
XTX Topco Ltd
Virtu Financial LLC
Organization | Bruush Oral Care Inc |
Employees | 11 |
CEO | Mr. Aneil Singh Manhas |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$0.09
+0.0%
Keyarch Acquisition Corp
$0.09
+0.0%
Connexa Sports Technologies Inc
$0.09
+0.0%
Us Value Etf
$0.09
+0.0%
First Wave Biopharma Inc
$0.09
+0.0%
Global X Msci Next Emerging
$0.09
+0.0%
Fat Projects Acquisition Corp
$0.09
+0.0%
Capital Link Global Fintech
$0.09
+0.0%
Applied Uv Inc
$0.09
+0.0%